Abeille pursues a flexible approach to its business development activities. Abeille is focused on developing products that address unmet needs in oncology supportive care and diabetes and related metabolic disorders.

Our approach includes consideration of:

• The formation of 'strategic' alliances
• Funding from pharmaceutical companies through development agreements and/or equity stakes
• Sharing risk and reward with partners
• The acquisition of technologies to complement and/or extend skill and capability bases

Abeille actively seeks strategic alliances with both technology and marketing partners to provide routes to market for its drug products.

Inquiries should be directed to:

Suresh Borsadia
Phone: +1 (609) 951-2204
e-mail: sborsadia@abeillepharma.com

116 Village Boulevard    |    Suite 200    |    Princeton    |    NJ 08540-5799